Fresenius cumpara APP Pharmaceuticals Inc pentru 2,9 mld. euro
Furnizorul de servicii medicale Fresenius SE va cumpara producatorul american de medicamente APP Pharmaceuticals Inc cu pana la 4,6 mld. $ (2,9 mld. euro), potrivit presei internationale.
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2008/07/4871fa1bcf23b.jpg)
Cazul Fresenius-APP Pharmaceuticals nu este singurul in care un alt jucator din domeniul farma este interesat de un producator de medicamente generice.
Daiichi Sankyo a oferit 4,6 miliarde dolari (circa 2,9 miliarde euro) pentru compania indiana Ranbaxy Laboratories Inc. si Sanofi-Aventis SA a acordat luna trecuta 1,96 milarde de dolari (1,25 miliarde euro) pentru pachetul majoritar al Zentiva NV.
Suma pe care Fresenius este disponibil sa o platesca pentru compania americana este de 5,6 ori mai mare decat vanzarile pe 12 luni ale APP Pharmaceuticals Inc, potrivit datelor Bloomberg.
Spre comparatie, Sanofi plateste de 2,4 ori mai mult decat vanzarile Zentiva pe un an, iar Daiichi Sankyo – de 4,6 ori peste vanzarile Ranbaxy.
Fresenius Medical Care este prezent in Romania prin reteaua de centre de dializa Fresenius NeprhoCare.
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/themes/strawberry-daily-202207/assets/images/avatar.png){kind=avatar}
Alte articole
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Uniunea-Europeana-UE-e1722026507484-1200x676.jpg.webp)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/bosch_schillerhoehe_sh_img_w1160-2.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/draculaland-7.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/zelenski-4.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/chine.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/job-1-1.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Marinescu.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Duta.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Christine-Lagarde.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Radu-Marinescu.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Trendyol.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/mecanic_locomotiva-scaled.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/burduja.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Ilie-Bolojan-072.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Drinking-Water.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/taxi-fara-sofer.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/portofel-gol.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Gergely-Gulyas.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/Casa_julietei.jpg)
